John Young, MD, has been named chief medical officer of Accumetrics (San Diego). Young will serve in a part-time capacity in addition to his current appointment as professor of medicine and director of the Cardiovascular Innovations program at Ohio State University (Columbus). He will serve as the main liaison to practicing clinicians, as well as coordinating ongoing research efforts and educational strategies for the company. Accumetrics is a provider of diagnostic tests for rapid platelet function assessment.

Douglas MacLellan has been named CEO/executive chairman of AMDL (Tustin, California). In addition, Michael Boswell was named to the board and will assume MacLellan's former role as chairman of AMDL's audit committee. MacLellan is transitioning into his new role after nearly 16 years on AMDL's board. He was appointed to the board in 1992 and became chairman of the audit and governance committees in 2001. Boswell is co-founder of the TriPoint family of companies and co-founder of TriPoint Capital Advisors. AMDL also reported the promotion of CFO Akio Ariura to COO/CFO. The company also is expanding its management team with the addition of Christopher Gee as director of international marketing and sales and Raymond Gatchalian as director of compliance and information technology. Ariura joined AMDL in 2006 as CFO. Gee is a former Apple executive and tech/biotech industry veteran with extensive IT, business operations, and international sales and marketing management experience. Gatchalian has an extensive background in IT audit and compliance. AMDL is a biopharmaceutical company focused on diagnostic, pharmaceutical, nutritional supplement, and cosmetic products.

• BD (Becton, Dickinson; Franklin Lakes, New Jersey) has named Vincent Forlenza president, effective Jan. 1, 2009, and David Elkins executive VP/CFO, effective Dec. 1. Forlenza joined BD in 1980. His prior roles include service in all three business segments, including service as GM of hypodermic-Europe; president, Becton Dickinson Microbiology Systems; senior VP, technology, strategy and development; and president, BD Biosciences. Elkins joins BD from AstraZeneca, where he has served since 2006 as VP/CFO of North America and global marketing.

Laurence Rea has been named vice president of operations at Great Basin Scientific (Salt Lake City), a privately held life sciences company developing point-of-care molecular diagnostic solutions. Rea will be responsible for creating the regulatory, manufacturing and quality control systems and staffing needed to take the company's molecular diagnostic products through clinical trials and to market. He also will oversee the set-up of the company's manufacturing facilities in Longmont, Colorado. Rea brings to Great Basin Scientific more than 20 years of engineering and manufacturing experience, of which eight years were spent managing BioStar, a unit of Inverness Medical Innovations. As general manager, Rea was responsible for FDA regulatory requirements and the overall performance of the business unit.

• Home Diagnostics (Fort Lauderdale, Florida) said that the board has retained the executive search firm DavenportMajor to recruit a successor to President/CEO J. Richard Damron Jr., who will be departing the company following a transition. Damron will remain in his present role until a transition is completed, which is expected to be in the first half of 2009. Home Diagnostics makes diabetes management solutions.

John Tamerius, PhD, has been promoted to senior vice president, clinical/regulatory affairs, at Quidel (San Diego), from his present position as vice president, clinical/regulatory affairs. Tamerius has been with Quidel for 25 years. He has served as vice president, clinical/regulatory affairs since 2005, and previously held a variety of executive roles, including responsibility for research and development and general management of Northern California operations. Quidel is a maker of rapid point-of-care diagnostic tests.